🔎 Trials Near Me

Akèy › Twoub depresif majè › Oklahoma › Oklahoma City

Etid klinik pou Twoub depresif majè nan Oklahoma City, OK

9 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Sooner Clinical Research, Oklahoma City
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Ap rekriteFaz 3
  • Sooner Clinical Research, Oklahoma City
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • Pahl Pharmaceutical Professionals Llc, Oklahoma City
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Oklahoma City
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07196501

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 2
  • Sooner Clinical Research /ID# 277659, Oklahoma City
Laj 18 a 65 · Tout sèks · Mizajou Jun 15, 2026 · NCT07276997

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Ap rekriteFaz 2
  • Autobahn Site #107, Oklahoma City
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016

Study of ALTO-300 in MDD

Ap rekriteFaz 2
  • Site 195, Oklahoma City
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Oklahoma City
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Oklahoma City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.